Fenna van Dijk

Fusies & Overnames / Ondernemingsrecht / Joint Ventures / Corporate governance / Governance in de zorg / Materiële controle / Samenwerkingen in de zorg / Medische hulpmiddelen

Fenna geeft leiding aan het Gezondheidszorg Team van Kennedy van der Laan.

Ze heeft meer dan 10 jaar ervaring in de gezondheidszorg. Haar focus ligt hier al sinds 2013. Ze is een van de weinige advocaten in Nederland die haar achtergrond in ondernemingsrecht combineert met een volledige focus op de gezondheidszorg.

Fenna is co-auteur van het boek 'Samenwerken tussen zorgorganisaties', een co-productie tussen Kennedy Van der Laan en organisatieadviesbureau Q-Consult Zorg dat eind augustus 2019 verscheen bij Bohn Stafleu Van Loghum. Het handboek behandelt op toegankelijke wijze de bedrijfskundige, fiscale, juridische en organisatorische aspecten van krachtenbundeling in de zorg. Aanleiding voor het boek zijn ingrijpende veranderingen in de zorgsector, die steeds vaker vragen om samenwerkingen en joint ventures.

Fenna is auteur van het tijdschrift Goed Bestuur en Toezicht en is vaste docent van het programma PCS van Governance University. Fenna geeft regelmatig les over governance en zorg voor Lexlumen.

The Legal 500 EMEA 2024 - Healthcare & Life Sciences - Ranked

A 'large team with very broad and in-depth knowledge', Kennedy Van der Laan‘s practice is known for advising a diverse range of medical device companies and institutes, with a particular specialism in the oncology space. Practice co-head Fenna van Dijk is noted for her longstanding corporate expertise, advising numerous directors of healthcare institutions and branch organisations on collaborations and M&A, while Eline Lam is well versed in governance and collaboration mandates. IP specialist and co-head Maarten Schut is particularly adept at handling matters concerning trade secrets and publishing for academic hospitals and other not-for-profit institutions. Additionally, Schut regularly represents clients in negotiations and disputes concerning R&D and licensing. Anne ten Brummelhuis has vast knowledge of patient rights, tariff regulation, the Youth Act, and the Social Support Act, allowing her to handle a range of e-health and regulatory mandates.

Leading individuals

Fenna van Dijk

Testimonials

• ‘Kennedy Van de Laan (Fenna van Dijk and Eline Lam) has helped us, having the great ability to thoroughly understand our questions and wishes, and translate regulations and legal aspects into daily practice within our organisation. Fenna van Dijk and Eline Lam are great individuals to work with. Very professional, flexible, and forward thinking.’
• ‘Fenna van Dijk is a great professional to work with. She has a lot of experience and knowledge, always thinks ahead and from our perspective as a client and has a great ability to connect. We can really trust her advice and she is very involved with us as clients.’
• ‘Kennedy Van der Laan has the required specific knowledge of the healthcare sector in combination with IT; in our opinion, that is their unique selling point. Fenna van Dijk’s team focuses on collaboration in healthcare and is involved in many respects with various stakeholders in the chain, such as (large) software parties, healthcare providers, but also relevant regulators.’
• ‘Fenna van Dijk has the necessary knowledge and experience. She is decisive, sharp in her advice and knows how to deliver a message. In addition, she is also able to understand risks and knows when to consult a fellow expert.’

Chambers Europe 2023 - Healthcare - Ranked

Fenna van Dijk of Kennedy Van der Laan is a valued presence on corporate concerns in the healthcare sector, including M&A and governance matters. She additionally advises on information sharing issues. "Fenna is very responsive. She is one of our trusted advisers."

Chambers Europe 2024 - Healthcare - Ranked

Fenna van Dijk of Kennedy Van der Laan is a valued presence on corporate concerns in the healthcare sector, including M&A and governance matters. She additionally advises on information sharing issues. "She always gives us very solid advice, keeps in mind the needs and strategic wishes of our organisation and is able to tackle and help us with diverse and complex issues."

The Legal 500 EMEA 2023 - Healthcare & Life Sciences - Ranked

Jointly led by healthcare expert Fenna van Dijk and life sciences specialist Maarten Schut, Kennedy Van der Laan's team handles the full breadth of mandates across the healthcare and life sciences segments. Combining a corporate background with a focus on healthcare, Van Dijk advises on market entry, licenses, clinical research, PPPs and drafting contracts with medical devices companies; she played a key role in the vaccine strategy concerning the Covid-19 pandemic. IP expert Schut advises multinational companies including Nutreco and Syngenta and not-for-profit institutions on conflicts relating to R&D and licensing. With the addition of Joran Spauwen, the practice has gained a specialist in IP-focused transactions in the advanced technologies sector, assisting healthcare service providers with medical devices regulation and negotiating contracts with AI suppliers. He also links the M&A practice to the healthcare and life sciences practice, focusing on innovative companies investing in the health tech industry. Counsel Sophie Van Loon specialises in contract drafting, advisory work and litigation within the life sciences field and associate Eline Lam focuses on corporate, healthcare and regulatory law.

Leading individuals

Fenna van Dijk

Testimonials

‘Fenna van Dijk and Eline Lam are not only very involved, but also accurate and reliable and think ahead in solving problems. They see not only the legal obstacles, but also the solutions and possibilities.’

Chambers Europe 2023 - Healthcare - Ranked

Fenna van Dijk of Kennedy Van der Laan is a valued presence on corporate concerns in the healthcare sector, including M&A and governance matters. She additionally advises on information sharing issues. "Fenna is very responsive. She is one of our trusted advisers."

The Legal 500 EMEA 2022 - Healthcare & Life Sciences - Ranked

The team at Kennedy Van der Laan is ‘knowledgeable, practical in its approach, pleasant to deal with and delivers a high-quality product’. It is well known in the market for advising clients on corporate, governance, compliance, competition and financing matters. Fenna van Dijk co-heads the practice with over two decades of experience in commercial work; Maarten Schut also heads the team and is recommended for IP. Joran Spauwen is a new election to the partnership.

Chambers Europe 2022 - Healthcare - Ranked

Fenna van Dijk of Kennedy Van der Laan is a valued presence on corporate concerns in the healthcare sector, including M&A and governance matters. She additionally advises on information sharing issues. Clients value her pragmatism, noting her skill in "deducing what politics are in the background and reacting accordingly."

Chambers Europe 2021 - Healthcare - Ranked

Fenna van Dijk undertakes a variety of corporate matters in the healthcare sector, including acquisitions, sales and governance structures. She also advises on litigation, data protection and contractual matters.

The Legal 500 EMEA 2020 - Healthcare & Life Sciences - Ranked

At Kennedy Van der Laan, Fenna van Dijk assists healthcare clients with corporate matters, and IP specialist Maarten Schut advises on a range of issues in the life sciences arena including R&D collaborations, licensing work and the protection of trade secrets. The team also acts for its healthcare clients on mergers, the establishment of joint ventures, medical liability cases, disciplinary actions and data protection mandates.

Chambers Europe 2020 - Healthcare - Ranked

Fenna van Dijk frequently acts for healthcare providers on a range of corporate matters, including acquisitions, joint ventures and governance structures. Additionally assists clients with market entries, contractual and compliance matters.

The Legal 500 EMEA 2019 - Industry focus: Healthcare and life sciences

Kennedy Van der Laan has a special focus on mergers and joint ventures together with medical liability and disciplinary actions. The team is a member of Biolegis, the pan-European network of independent law firms with a focus on life sciences. Fenna van Dijk heads the healthcare team and Maarten Schut specialises in IP within the life sciences sector. Meltem Koning advises on corporate and private equity matters. The group advised the Oncode Institute, a new ‘super’ institute combining oncology research from numerous academic hospitals and research institutes. It assisted with its set up and governance, funding negotiations, and complex IP arrangements. In other work includes advising on licensing, R&D collaborations, and patent disputes.

Chambers Europe 2019 - Healthcare - Ranked

Interviewees admire Fenna van Dijk for her "personal touch and real commitment." She acts on a range of corporate mandates relating to the healthcare sector, including mergers, joint ventures and the establishment of institutions. Clients also praise her governance work, saying: "She understands complex issues and gives the most appropriate answer to questions quickly and efficiently."

Chambers Europe 2018 - Healthcare - Ranked

"Fenna van Dijk specialises in corporate law, advising hospitals, medical organisations and healthcare investors on mergers and the setting up of healthcare institutions. Clients appreciate that she "tries to understand our issues and to learn how we operate."

The Legal 500 EMEA 2018 - Healthcare

"The ‘friendly’ practice at Kennedy Van der Laan counts Ambulance Amsterdam and VUmc as clients. Fenna van Dijk and IP expert Maarten Schut head the healthcare and life sciences teams respectively; van Dijk assisted GGZ inGeest with transferring its youth mental healthcare activities to De Opvoedpoli."